Vanda Pharmaceuticals VNDA
NASDAQ VNDA
$5.43 +0.09 (+1.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vanda Pharmaceuticals (VNDA) Current Deferred Tax Assets (2010 - 2011)

Vanda Pharmaceuticals (VNDA) posted Current Deferred Tax Assets of $182000.0 for Q3 2011, little changed sequentially from $182000.0 in Q2 2011.

Analysis

Vanda Pharmaceuticals (VNDA) Current Deferred Tax Assets (2010 - 2011) Analysis & Trends

Vanda Pharmaceuticals has reported Current Deferred Tax Assets for 2 years, with the latest figure at $182000.0 in Q3 2011.

  • Quarterly Current Deferred Tax Assets changed N/A year-over-year to $182000.0 in Q3 2011, while the trailing twelve-month figure through Sep 2011 was $182000.0 (changed N/A YoY) and the FY2010 annual result came in at $182000.0, changed N/A from the prior year.
  • Current Deferred Tax Assets held at $182000.0 in Q3 2011 per VNDA's latest filing, from $182000.0 in the prior quarter.
  • Over five years, Current Deferred Tax Assets peaked at $182000.0 in Q4 2010 and troughed at $182000.0 in Q4 2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Vanda Pharmaceuticals 327.03 Mn 157.00 Mn 46.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2011 182,000.00
Jun 30, 2011 182,000.00
Dec 31, 2010 182,000.00